Do More With Reuters
Partner Services

Company Profile For Zeltia SA

Zeltia SA (ZEL.MC) (Madrid SE C.A.T.S.)
sector: Basic Materials · industry: Chemicals - Diversified ·
As of  25 Nov 2009
4.20EUR
Price Change
-0.00
Percent Change
-0.12%
 
Research a stock:   symbol lookup
 

Overview

Zeltia SA is a Spain-based holding company primarily engaged, through its subsidiaries, in the chemical and pharmaceutical sectors. Its main subsidiaries are: PharmaMar SA, biopharmaceutical company committed to advancing the treatment of cancer; Noscira SA, engaged in the research and development of innovative drugs for diseases of the nervous system; Genomica SAU, specializes in molecular diagnosis; Sylentis SAU, focused on the discovering and developing new therapeutic approaches based on gene silencing techniques; Zelnova SA, which produces and markets cleaning products for household and cetring sectors; and Xylazel SA, producer of paints, varnishes, wood and metal protectors for the industrial sector.

Quick Financial Synopsis

BRIEF: For the nine months ended 30 September 2009, Zeltia SA's total revenue increased 20% to EUR111.4M. Net loss decreased 40% to EUR15.1M. Total revenue reflects favorable market conditions as well as an increase in demand for the Company's products and services. Lower net loss for the period reflects a significant increase in general and administrative expenses as well as higher marketing expenses.

Company Address

Zeltia SA
C/ Jose Abascal 2
Madrid   MAD   28003
P: +3491.4444500
F: +3491.5932954

Total Employees

684

Company Web Links

Find Out More About ZEL.MC

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives

Commodities

Commodity Last Pct Chg Trade Date/Time
Oil 77.83 -0.78% 11/26 12:38 IST
Gold 1193.4 +0.54% 11/26 12:18 IST